|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/13 | |
| A61K 9/48 | |||
| A61K 9/50 | |||
| A61P 21/00 |
| (11) | Number of the document | 3215132 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15857591.0 |
| Date of filing the European patent application | 2015-11-03 | |
| (97) | Date of publication of the European application | 2017-09-13 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/058872 |
| Date | 2015-11-03 |
| (87) | Number | WO 2016/073510 |
| Date | 2016-05-12 |
| (30) | Number | Date | Country code |
| 201462075137 P | 2014-11-04 | US |
| (72) |
WENT, Gregory T., US
FULTZ, Timothy J., US
NGUYEN, Jack, US
CHERNOFF, David, US
|
| (73) |
Adamas Pharmaceuticals, Inc.,
1900 Powell Street, Suite 750, Emeryville, CA 94608,
US
|
| (54) | AMANTADINE FOR IMPROVING GAIT IN MULTIPLE SCLEROSIS |
| AMANTADINE FOR IMPROVING GAIT IN MULTIPLE SCLEROSIS |